KEYWORDS: Patient-derived organoids urothelial cancer bladder cancer drug response prediction drug discovery antibody drug conjugates immune checkpoint inhibitors 1. State-of-the-art Bladder cancer (BC) displays extensive inter- and intratumoral heterogeneity at histologic, molecular, and microenvironmental levels.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Christian
Contact Christian, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack